share_log

HC Wainwright & Co. Maintains Buy on Replimune Group, Lowers Price Target to $48

HC Wainwright & Co. Maintains Buy on Replimune Group, Lowers Price Target to $48

HC Wainwright & Co.维持对Replimune集团的买入,将目标价下调至48美元
Benzinga ·  2023/11/13 18:07

HC Wainwright & Co. analyst Robert Burns maintains Replimune Group (NASDAQ:REPL) with a Buy and lowers the price target from $50 to $48.

HC Wainwright & Co. 分析师罗伯特·伯恩斯维持Replimune集团(纳斯达克股票代码:REPL)的买入,并将目标股价从50美元下调至48美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发